Workflow
BridgeBio Pharma, Inc. (BBIO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Question-and-Answer SessionNeil KumarCo-Founder, CEO & Director Sure. Yes. Thanks for the question. So as I think many in the room know, this year has really been focused on the Attruby launch and proving that we can marry what I've seen is a high degree of R&D productivity with some commercial productivity and obviously, a lot more to do on that launch, but we're happy with how that's been evolving. And so where that really brings us right now is on the cusp of becoming, as you just mentioned, a multiprodu ...